Upside – $MEDS +36% (preliminary September pharmacy revenue exceeded $1M, rising more than 66% from July) – $ACN +17% (Q4 beat with $22.2B of bookings and stronger operating margins) – $ABAT +13% (receives federal approval to export up to $100M of recycled black-mass material) – $QSI +13% (no clear fresh catalyst identified; unusually large move …
Read in context ›Protara Therapeutics Stock (TARA)
Track Protara Therapeutics stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
TARA
Protara Therapeutics
healthcare
At close
$2.76
▲ +0.10 (+3.96%)
Oct 9, 4:00 PM ET
After-hours
$2.76
• +0.00 (0.00%)
Oct 9, 7:30 PM ET
Market Cap
$156.60M
P/E Ratio
—
1Y Return
-47.73%
EPS (TTM)
-$1.35
Read the latest TheStreet Pro articles mentioning Protara Therapeutics, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning TARA yet.
Daily Diary Mentions
1 mentionUpside, Downside Movers in the Morning